HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Preemption In Cosmetics Bill Would Offset Burden, But To What Degree?

This article was originally published in The Rose Sheet

Executive Summary

States would be barred from establishing cosmetic ingredient restrictions that conflict with final FDA review determinations, as well as requirements related to cosmetics registration, good manufacturing practices or adverse-event reporting, under a preemption clause in the Personal Care Products Safety Act, introduced April 20. The bill would help address the growing problem of inconsistent regulations from one state to the next, but exceptions and potential gray areas raise questions about how effective the provision would be.

Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS019464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel